US-based Allergan Inc today announced the launch of its anaesthetic dermal filler ‘Juvederm XC’, used to correct facial imperfections, in the country. (Source: The Economic Times Healthcare and Biotech News)
Allergan, Inc. (NYSE:AGN) announced the U.S. Food and Drug Administration’s (FDA) approval of JUVEDERM(R) XC, a new formulation of the currently FDA-approved JUVEDERM(R) dermal filler and the latest advancement1 in hyaluronic acid (HA) dermal fillers.
SAN MATEO, Calif. and PARIS, Jan. 8, 2009 (GLOBE NEWSWIRE) — BioForm Medical, Inc.
Only Hyaluronic Acid Dermal Fillers Approved to Last up to 1 Year IRVINE, Calif.–(HSMN NewsFeed)–Allergan, Inc. (NYSE:AGN ), the maker of BOTOX? Cosmetic (Botulinum Toxin Type A), today announced approval by the U.S.
Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store